The table below shows Teladoc Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$9.52M
$15.92M
$8.92M
$13.16M
-$31.75M
-$18.03M
Capital expenditure
$1.66M
$2.73M
$1.15M
$2.36M
$3.91M
$2.12M
Investing cash flow
-$36.52M
-$123.27M
-$35.51M
-$45.62M
-$27.57M
-$16.03M
Dividends paid
-
-
-
-
TDOC operating cash flow (10-K history)
Teladoc Health, Inc. reported operating cash flow of $294.36M for fiscal year 2025. That is up 0.2% from $293.68M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$51.88M (FY 2016) to $294.36M. Figures come from the company's audited annual reports as filed with the SEC.
